REGENERON PHARMACEUTICALS

Veopoz

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

REGENERON PHARMACEUTICALS

Veopoz HCPCS:

J9376

HCPCS Code Descriptor:

Injection, pozelimab-bbfg, 1 mg

Category:

J Code

Veopoz NDCs:

61755-0014-01,

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Veopoz CPT Codes:

Potential CPT administration codes for Veopoz can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Veopoz:

Veopoz is manufactured by REGENERON PHARMACEUTICALSand aligned to the J Code: J9376. Veopoz is a Immunosuppressant medication administered via the Intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J9376 Added Date:

April 1, 2024

J9376 Effective Date:

April 1, 2024

J9376 Termination Date:

HCPCS Active

We have not identified a manufacturer-published billing and coding guide for Veopoz
Our team has not identified a source of patient assistance information for Veopoz
Veopoz prescribing information can be found at the link below:
Our team has not yet identified a source of side effect information for Veopoz.